[go: up one dir, main page]

EE200100539A - Prukalopriidi vesilahus suukaudseks manustamiseksning selle valmistamismeetod - Google Patents

Prukalopriidi vesilahus suukaudseks manustamiseksning selle valmistamismeetod

Info

Publication number
EE200100539A
EE200100539A EEP200100539A EEP200100539A EE200100539A EE 200100539 A EE200100539 A EE 200100539A EE P200100539 A EEP200100539 A EE P200100539A EE P200100539 A EEP200100539 A EE P200100539A EE 200100539 A EE200100539 A EE 200100539A
Authority
EE
Estonia
Prior art keywords
prucalopride
preparation
aqueous solution
oral administration
oral
Prior art date
Application number
EEP200100539A
Other languages
English (en)
Inventor
Andr� Jos�e De Proost Eddy
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200100539A publication Critical patent/EE200100539A/et
Publication of EE05264B1 publication Critical patent/EE05264B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EEP200100539A 1999-04-29 2000-04-20 Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod EE05264B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (2)

Publication Number Publication Date
EE200100539A true EE200100539A (et) 2002-12-16
EE05264B1 EE05264B1 (et) 2010-02-15

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100539A EE05264B1 (et) 1999-04-29 2000-04-20 Prukalopriidi vesilahus suukaudseks manustamiseks ning selle valmistamismeetod

Country Status (36)

Country Link
US (1) US6413988B1 (et)
EP (1) EP1176982B1 (et)
JP (1) JP4773619B2 (et)
KR (1) KR100669175B1 (et)
CN (1) CN1165345C (et)
AR (1) AR023815A1 (et)
AT (1) ATE254929T1 (et)
AU (1) AU770073B2 (et)
BG (1) BG65061B1 (et)
BR (1) BRPI0010150B8 (et)
CA (1) CA2371178C (et)
CZ (1) CZ294070B6 (et)
DE (1) DE60006799T2 (et)
DK (1) DK1176982T3 (et)
EA (1) EA003904B1 (et)
EE (1) EE05264B1 (et)
ES (1) ES2211546T3 (et)
HK (1) HK1045950B (et)
HR (1) HRP20010764B1 (et)
HU (1) HU228924B1 (et)
ID (1) ID30397A (et)
IL (2) IL146152A0 (et)
JO (1) JO2181B1 (et)
MX (1) MXPA01010953A (et)
MY (1) MY119880A (et)
NO (1) NO331448B1 (et)
NZ (1) NZ515119A (et)
PL (1) PL195674B1 (et)
PT (1) PT1176982E (et)
SI (1) SI1176982T1 (et)
SK (1) SK284847B6 (et)
TR (1) TR200103121T2 (et)
TW (1) TW592709B (et)
UA (1) UA68426C2 (et)
WO (1) WO2000066170A1 (et)
ZA (1) ZA200108820B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
WO2002041918A2 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1789067B8 (en) 2004-08-12 2012-08-15 Helsinn Healthcare S.A. Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system
GB201103397D0 (et) * 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
CN119700664B (zh) * 2025-02-28 2025-06-20 山东新时代药业有限公司 含有活性成分琥珀酸普芦卡必利的注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
CA2352278A1 (en) * 1998-11-23 2000-06-02 Janssen Pharmaceutica, N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
IL146152A0 (en) 2002-07-25
NO20014794D0 (no) 2001-10-02
CA2371178C (en) 2008-03-25
TR200103121T2 (tr) 2002-05-21
TW592709B (en) 2004-06-21
BRPI0010150B8 (pt) 2021-05-25
PT1176982E (pt) 2004-04-30
DK1176982T3 (da) 2004-03-29
BG65061B1 (bg) 2007-01-31
HK1045950A1 (en) 2002-12-20
EA003904B1 (ru) 2003-10-30
NO331448B1 (no) 2012-01-02
HRP20010764A2 (en) 2002-12-31
MXPA01010953A (es) 2002-05-06
CZ294070B6 (cs) 2004-09-15
SK15192001A3 (sk) 2002-03-05
US6413988B1 (en) 2002-07-02
HRP20010764B1 (hr) 2011-01-31
PL352062A1 (en) 2003-07-28
CA2371178A1 (en) 2000-11-09
AR023815A1 (es) 2002-09-04
HU228924B1 (en) 2013-06-28
ES2211546T3 (es) 2004-07-16
EE05264B1 (et) 2010-02-15
EP1176982A1 (en) 2002-02-06
HUP0202324A2 (hu) 2002-12-28
DE60006799D1 (de) 2004-01-08
UA68426C2 (uk) 2004-08-16
BR0010150A (pt) 2002-01-15
CN1165345C (zh) 2004-09-08
EP1176982B1 (en) 2003-11-26
CZ20013735A3 (cs) 2002-02-13
PL195674B1 (pl) 2007-10-31
NZ515119A (en) 2003-05-30
AU770073B2 (en) 2004-02-12
KR20020004972A (ko) 2002-01-16
NO20014794L (no) 2001-10-02
HUP0202324A3 (en) 2003-03-28
JP4773619B2 (ja) 2011-09-14
EA200101150A1 (ru) 2002-04-25
WO2000066170A1 (en) 2000-11-09
JP2002543161A (ja) 2002-12-17
MY119880A (en) 2005-07-29
SI1176982T1 (en) 2004-04-30
HK1045950B (zh) 2005-05-27
KR100669175B1 (ko) 2007-01-17
SK284847B6 (sk) 2006-01-05
BG106031A (en) 2002-05-31
AU4913700A (en) 2000-11-17
ZA200108820B (en) 2003-01-27
IL146152A (en) 2006-12-31
ID30397A (id) 2001-11-29
BRPI0010150B1 (pt) 2015-06-23
CN1348386A (zh) 2002-05-08
JO2181B1 (en) 2003-04-23
ATE254929T1 (de) 2003-12-15
DE60006799T2 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
DE69936002D1 (de) Angepasster löffel zur oralen medikamenten-verabreichung
EE04417B1 (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm, selle valmistamise meetod ja kasutamine
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
IL148407A0 (en) Oral pharmaceutical forms of administration with a delayed action
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
NO20014738D0 (no) Tolperisonholdig farmasöytisk preparat for oral administrering
PT1230230E (pt) Derivados de indeno-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorexigenico
EE04955B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
EE200100539A (et) Prukalopriidi vesilahus suukaudseks manustamiseksning selle valmistamismeetod
ATE273697T1 (de) Pharmazeutische levothyroxinzubereitung
DE60110666D1 (de) Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren
NO20013205L (no) Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler
EE05168B1 (et) N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE200100615A (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
EP1233755A4 (en) GRANULES OF MEDICINAL SALTS WITH HYDROLIZED CELLULOSE
EE05230B1 (et) Suukaudselt manustatav galantamiinilahus ja meetod selle valmistamiseks
EE05050B1 (et) Loteprednooli ja β2-adrenoretseptori agonistide kombinatsioon, selle kasutamine, seda kombinatsiooni sisaldav farmatseutiline preparaat ja ravim ning meetod seda kombinatsiooni sisaldava ravimivalmistamiseks
IL150403A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
EE04611B1 (et) Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina
IL150402A0 (en) NOVEL PROCESS FOR THE PREPARATION OF α-(2-4-DISULFOPHENYL)-N-TERT-BUTYLNITRONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
DE60001768D1 (de) Tezosentan enthaltende wässerige pharmazeutische Zubereitung
NO20003284L (no) Farmasøytisk preparat for oral administrering
GB9930266D0 (en) Oral administration of beneficial substances

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name